학술논문

P13: CAN PATIENT‐REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Document Type
Article
Source
HemaSphere; Apr2022 Supplement 1, Vol. 6, p18-18, 1p
Subject
Language
ISSN
25729241